Michael Randall Giuffre - Director, Diamedica Therapeutics Inc

As of July 16, 2021


Michael Randall Giuffre Net Worth

  • Net worth is estimated to be at least $363.12K
  • Owns at least 162,774 units of Diamedica Therapeutics Inc stock

Michael Randall Giuffre Trading

  • Largest purchase of shares was 15,000 units , worth over $63.91K on November 23, 2020
  • In total has made about 6 transactions over 3 years
  • Usually trades in June, with the busiest year in 2020 and 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Michael Randall Giuffre Mailing Address

  • Mailing address is 2 Carlson Parkway Suite 260 Minneapolis MN 55447 MN

Diamedica Therapeutics Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Rick Pauls 2020 $455,013 - $190,624 $217,716 $14,850 $878,203
Rick Pauls 2019 $420,000 - $890,736 $178,000 $14,650 $733,707
Scott Kellen 2020 $276,075 - $119,140 $79,238 $14,850 $489,303
Scott Kellen 2019 $262,500 - $336,557 $64,800 $13,950 $677,807
Harry Alcorn, Jr., Pharm.D. 2020 $291,413 - $119,140 $83,662 $14,850 $509,065
Harry Alcorn, Jr., Pharm.D. 2019 $273,750 - $421,750 $68,400 $14,400 $778,300
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1401040/000143774921014066/dmtp20210406_def14a.htm

Diamedica Therapeutics Inc Insider Trading

  • The most recent transaction was 15,000 units bought on September 15, 2021 by Harry Alcorn Jr worth over $56.96K
  • In the last 3 years, insiders at Diamedica Therapeutics Inc bought an estimated value of $1.05M
  • The most active traders are Richard Pilnik, Director,  Harry Alcorn Jr, SVP,  and Scott Kellen, CFO and Secretary
  • Insider trading is most common in June, with the busiest year in 2021

DiaMedica Therapeutics Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1